Femoropopliteal Interventions for Peripheral Artery Disease: A Review of Current Evidence and Future Directions

Adam P Johnson1, Rajesh V Swaminathan2, Samantha D Minc3

  • 1Department of Surgery, Division of Vascular and Endovascular Surgery, Duke University Health System, Durham, NC, USA; Durham Veterans Administration Medical Center, Durham, NC, USA.

Insights

Peripheral artery disease affecting the femoropopliteal segment can cause limb-threatening ischemia. This review summarizes current medical, endovascular, and surgical treatments for femoropopliteal artery occlusive disease.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Peripheral Artery Disease

Background:

  • The femoropopliteal segment is a frequent site for peripheral artery disease (PAD).
  • PAD in this region can manifest as claudication or critical limb ischemia, particularly with multilevel disease.
  • Treatment options for femoropopliteal occlusive disease are diverse.

Purpose of the Study:

  • To review current medical, endovascular, and surgical therapies for femoropopliteal artery occlusive disease.
  • To summarize evolving management strategies based on patient factors and disease severity.

Main Methods:

  • Literature review of current therapeutic options for femoropopliteal PAD.
  • Synthesis of evidence regarding medical, exercise, endovascular, and open surgical interventions.

Main Results:

  • Multiple treatment modalities exist for femoropopliteal artery occlusive disease.
  • Management algorithms are evolving with advancements in endovascular and surgical techniques.
  • Therapeutic goals vary based on patient presentation and disease extent.

Conclusions:

  • Optimal management of femoropopliteal PAD requires consideration of patient-specific factors and disease characteristics.
  • A comprehensive understanding of available therapies is crucial for effective treatment planning.
  • Continued research is needed to refine best practices for femoropopliteal artery disease.